2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Breast Neoplasms
10
Colonic Neoplasms
9
Prostatic Neoplasms
8
Colorectal Neoplasms
6
Neoplasms
5
Multiple Myeloma
4
Uterine Cervical Neoplasms
3
Stomach Neoplasms
3
Smoldering Multiple Myeloma
3
Rectal Neoplasms
3
Pancreatic Neoplasms
3
Monoclonal Gammopathy of Undetermined Significance
3
Lung Neoplasms
3
Adenomatous Polyposis Coli
3
Uterine Cervical Dysplasia
2
Radiodermatitis
2
Pain
2
Esophageal Neoplasms
2
Breast Carcinoma In Situ
2
cyclopia sequence
1
Uterine Neoplasms
1
Tuberous Sclerosis
1
Thrombocythemia, Essential
1
Stomatitis
1
Sezary Syndrome
1
Seizures
1
Psychological Well-Being
1
Prostate Cancer Metastatic Castration Resistant
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Interventions
Cyclophosphamide
413
Methotrexate
250
Cytarabine
235
Vincristine
192
fludarabine phosphate
174
Dexamethasone
171
fludarabine
147
Etoposide
143
Peripheral Blood Stem Cell Transplantation
137
Filgrastim
132
Whole-Body Irradiation
118
Mycophenolic Acid
116
Busulfan
113
Doxorubicin
110
Mercaptopurine
109
Tacrolimus
107
Cyclosporine
95
Radiotherapy
93
Melphalan
93
pegaspargase
90
Rituximab
90
Prednisone
88
Asparaginase
87
Daunorubicin
86
Granulocyte Colony-Stimulating Factor
76
blinatumomab
74
Antilymphocyte Serum
71
Calcium Dobesilate
69
Clofarabine
58
Thiotepa
55
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Precursor Cell Lymphoblastic Leukemia-Lymphoma
×
Curcumin
×
Clear all
NCT05045443
2024-01-08
CurcumPedALL
Ain Shams University
Phase 2
Completed
30 enrolled